Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Sotera Health (SHC) Net Margin (2020 - 2026)

Sotera Health has reported Net Margin over the past 6 years, most recently at 11.48% for Q4 2025.

  • For Q4 2025, Net Margin rose 724.0% year-over-year to 11.48%; the TTM value through Dec 2025 reached 6.7%, up 266.0%, while the annual FY2025 figure was 6.7%, 266.0% up from the prior year.
  • Net Margin for Q4 2025 was 11.48% at Sotera Health, down from 15.55% in the prior quarter.
  • Over five years, Net Margin peaked at 16.92% in Q2 2021 and troughed at 127.08% in Q4 2022.
  • A 5-year average of 0.74% and a median of 7.58% in 2023 define the central range for Net Margin.
  • Biggest five-year swings in Net Margin: skyrocketed 45316bps in 2021 and later tumbled -14200bps in 2022.
  • Year by year, Net Margin stood at 14.92% in 2021, then plummeted by -952bps to 127.08% in 2022, then surged by 110bps to 12.47% in 2023, then crashed by -66bps to 4.25% in 2024, then skyrocketed by 170bps to 11.48% in 2025.
  • Business Quant data shows Net Margin for SHC at 11.48% in Q4 2025, 15.55% in Q3 2025, and 2.71% in Q2 2025.